Qube Research & Technologies (QRT)’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
783,846
+134,636
| +21% | +$2.9M | 0.02% | 695 |
|
|
2025
Q1 | $10.8M | Buy |
649,210
+17,788
| +3% | +$295K | 0.01% | 817 |
|
|
2024
Q4 | $11.6M | Buy |
631,422
+212,019
| +51% | +$3.89M | 0.02% | 771 |
|
|
2024
Q3 | $6.45M | Sell |
419,403
-685,703
| -62% | -$10.5M | 0.01% | 986 |
|
|
2024
Q2 | $18M | Buy |
1,105,106
+461,036
| +72% | +$7.49M | 0.03% | 511 |
|
|
2024
Q1 | $11.9M | Buy |
644,070
+363,811
| +130% | +$6.73M | 0.02% | 664 |
|
|
2023
Q4 | $8.77M | Buy |
280,259
+67,340
| +32% | +$2.11M | 0.02% | 647 |
|
|
2023
Q3 | $4.44M | Buy |
212,919
+188,080
| +757% | +$3.92M | 0.01% | 783 |
|
|
2023
Q2 | $595K | Buy |
+24,839
| New | +$595K | ﹤0.01% | 1400 |
|
|
2023
Q1 | – | Sell |
-30,721
| Closed | -$489K | – | 2420 |
|
|
2022
Q4 | $489K | Buy |
+30,721
| New | +$489K | ﹤0.01% | 1413 |
|
|
2022
Q2 | – | Sell |
-12,825
| Closed | -$311K | – | 2418 |
|
|
2022
Q1 | $311K | Buy |
+12,825
| New | +$311K | ﹤0.01% | 1752 |
|
|
2021
Q1 | – | Sell |
-48,226
| Closed | -$2.58M | – | 1860 |
|
|
2020
Q4 | $2.58M | Buy |
+48,226
| New | +$2.58M | 0.04% | 518 |
|
|
2020
Q3 | – | Sell |
-161,431
| Closed | -$7.83M | – | 1611 |
|
|
2020
Q2 | $7.83M | Buy |
+161,431
| New | +$7.83M | 0.11% | 217 |
|
|
2020
Q1 | – | Sell |
-5,940
| Closed | -$254K | – | 1071 |
|
|
2019
Q4 | $254K | Buy |
+5,940
| New | +$254K | 0.01% | 1299 |
|